Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2019
Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic CancerKyle C Cuneo, Meredith A Morgan, Vaibhav Sahai, et al.
Investigational New Drugs|March 7, 2018
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studiesHerbert Hurwitz, Eric Van Cutsem, Johanna Bendell, et al.
The Lancet. Oncology|March 6, 2020
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trialMichael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2020
Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancerRichard D Kim, Shannon McDonough, Anthony B El-Khoueiry, et al.
Neoplasia (New York, N.Y.)|June 2, 2023
Genomics driven precision oncology in advanced biliary tract cancer improves survivalChandan Kumar-Sinha, Pankaj Vats, Nguyen Tran, et al.
Cancer Discovery|May 18, 2016
GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic CancerMeghna Waghray, Malica Yalamanchili, Michele Dziubinski, et al.
JCO Precision Oncology|February 1, 2022
Palbociclib in Patients With Pancreatic and Biliary Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyTareq Al Baghdadi, Susan Halabi, Elizabeth Garrett-Mayer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2023
Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)Arathi Mohan, Kent A Griffith, Fulei Wuchu, et al.
The Lancet. Gastroenterology & Hepatology|December 5, 2025
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trialMilind Javle, Christos Fountzilas, Chih-Yi Liao, et al.
Nature Metabolism|July 23, 2020
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumoursZiwen Zhu, Abhinav Achreja, Noah Meurs, et al.
Pageof 11